The S&P/ASX 200 Index (ASX: XJO) is having another strong session on Thursday. In afternoon trade, the benchmark is up 1.1% to 9,107.7 points.
Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are falling:
Image source: Getty Images
Goodman Group (ASX: GMG)
The Goodman share price is down almost 7% to $28.96. Investors have been selling this industrial property giant's shares following the release of its half-year results. Goodman reported an operating profit of $1.2 billion thanks to a combination of new developments, 95.9% portfolio occupancy, and like-for-like net property income growth of 4.2%. Looking ahead, management reiterated a target of 9% growth in FY 2026 operating earnings per share. However, it notes that this remains subject to stable market conditions. It is possible that the market was expecting an upgrade to its guidance.
Lovisa Holdings Ltd (ASX: LOV)
The Lovisa share price is down 11% to $27.60. This is despite the fashion jewellery retailer releasing its half-year results and reporting a 23.3% increase in revenue to $500.7 million and a 21.5% jump in underlying net profit to $69.6 million. However, Lovisa's statutory net profit after tax, which includes its Jewells investment, was up just 2.6% to $58.4 million. The Jewells business recorded a loss of $11.2 million for the period.
Medibank Private Ltd (ASX: MPL)
The Medibank share price is down 6.5% to $4.48. This morning, the private health insurer released its half-year results and reported a 0.3% decline in underlying net profit after tax to $297.8 million. The main drag on its performance was its net investment income, which fell 17.1% to $94.9 million. Despite this, the Medibank board elected to increase its interim dividend to 8.3 cents per share. Medibank's CEO, David Koczkar, said: "This is another good result for the Medibank Group, reflecting strong customer engagement and positive progress in driving the health transition forward. We have delivered on our growth commitments, with improved momentum in our health insurance business and strong growth in Medibank Health."
Zip Co Ltd (ASX: ZIP)
The Zip share price is down 38% to $1.74. Investors have been selling the buy now pay later provider's shares following the release of its half-year results. Although Zip delivered a record result, investors appear concerned by a number of metrics. Zip's revenue margin edged lower to 7.9%, net bad debts increased slightly to 1.73% of TTV, and its second-half cash EBTDA is expected to be broadly in line with the first half. This suggests that profit growth may moderate from here rather than accelerate further.
